Most investors are asking: "Will Oscar beat earnings?" I think they're asking the wrong question. The real question is: Is $OSCR quietly becoming a healthcare platform instead of just an insurance company? That's the thesis behind my full earnings preview. I break down: • Why Lucie matters • Why ICHRA is bigger than most realize • The five metrics I'm watching • My earnings expectations • Why I believe Wall Street is still looking at Oscar through the wrong lens If I'm right, this earnings report is about much more than one quarter. Read Article here: https://t.co/aWYgpGRmTl
在 X 查看 ↗